查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1983868

血管内超音波市场：2026-2032年全球市场预测（依产品类型、血管内超音波模式、应用、最终用途及通路划分）

Intravascular Ultrasound Market by Product Type, IVUS Modalities, Application, End Use, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，血管内超音波市场价值将达到 26.7 亿美元，到 2026 年将成长至 28.4 亿美元，到 2032 年将达到 42.4 亿美元，复合年增长率为 6.85%。

主要市场统计数据
基准年 2025 26.7亿美元
预计年份：2026年 28.4亿美元
预测年份 2032 42.4亿美元
复合年增长率 (%) 6.85%

对血管内超音波技术的发展和临床应用进行基本概述，该技术影响着现代循环系统医学中的决策和设备选择。

血管内超音波（IVUS）已从单纯的辅助诊断工具发展成为第一线影像技术，对介入治疗策略和器械选择产生重大影响。近年来，声学阵列技术、高解析度成像模式以及导管设计的改进，缩小了血管内成像与即时手术指导之间的差距，使临床医生能够更自信地观察血管形态、量化斑块负荷并优化器械尺寸。因此，IVUS在复杂的冠状动脉和周边血管介入治疗中正发挥日益重要的作用，有助于提高手术精准度并可能改善临床疗效。

高解析度影像、软体自动化和临床证据的产生之间的变革性融合，正在重新定义血管内超音波在介入治疗计划中的作用。

血管内超音波（IVUS）的格局正因技术创新、不断完善的临床指南以及对术前结果的新期望而发生重塑。射频阵列导管和改进的讯号处理演算法能够更清晰地显示斑块成分和支架黏附情况，从而减少对透视影像推断的依赖。同时，能够自动提供管腔和斑块测量数据的先进软体套件，使得不同医生能够快速解读影像并产生一致的报告，从而支援对标准化手术终点和结果进行比较分析。

评估 2025 年美国关税变化如何促进血管内超音波(IVUS)相关人员的供应链重组、采购多元化和替代经营模式。

美国2025年实施的关税调整和贸易政策变化，对医疗影像硬体和一次性医疗器材的采购、供应链和定价策略产生了复杂的影响。对于依赖精密设计的导管、客製化换能器材料和主机电子元件的血管内超音波（IVUS）而言，进口关税的增加可能导致整体成本上升。为此，製造商正优先考虑区域采购多元化、关键零件的近岸生产以及设计改进，以减少对受关税影响的原材料的依赖，同时保持临床性能。

基于细分的引人入胜的见解，将临床应用、设备分类、最终使用环境以及在手术中的作用与可行的产品和商业化优先事项联繫起来。

深入的細項分析揭示了临床需求、产品设计和采购优先顺序在应用、装置类型、最终用途和治疗目标方面的交汇点。将应用领域划分为冠状动脉和周边血管领域，并将冠状动脉领域进一步细分为急性冠状动脉症候群和慢性完全闭塞，将外周血管领域细分为周边动脉疾病和外周静脉应用，结果表明，成像需求会因病变复杂程度、血管大小以及是否需要进行纵向血管评估而有所不同。这些临床差异决定了产品团队优先考虑的导管形状、频率选择和影像处理功能。

美洲、欧洲、中东和非洲以及亚太地区的区域采用模式和战略挑战，这些都影响着临床采用和商业化的路径。

了解区域趋势对于理解血管内超音波（IVUS）的应用模式和策略重点至关重要。在美洲，临床上对介入性心臟病学创新的重视、针对复杂手术的完善报销机制以及高病例医疗机构的集中，都促进了先进成像技术的应用和竞争激烈的服务市场。该地区的监管路径和采购惯例强调可靠的临床结果和成本效益论证，这影响供应商如何优先考虑临床证据和上市后监测。

本报告阐述了竞争与合作的动态，展示了硬体领导者、细分市场创新者和软体参与企业如何塑造血管内超音波(IVUS) 领域的产品差异化和市场定位。

血管内超音波（IVUS）领域的竞争动态持续利好那些能够整合卓越硬体、软体驱动的分析能力和强大的临床支援的机构。老牌医疗设备製造商凭藉规模优势、深厚的临床关係和全球分销网络保持领先地位，而专业成像领域的创新者则在图像分辨率、导管设计和工作流程整合方面展开竞争。新兴参与企业（包括中小型科技公司和软体开发人员）正挑战传统观念，专注于机器学习驱动的斑块分析、自动化报告和云端资料管理，以支援多中心註册研究和上市后证据收集。

为製造商和供应商提供具体的策略建议，以加速采用血管内超音波，协调证据产生、互通性、供应弹性和教育计画。

血管内超音波（IVUS）生态系统中的领导企业需要协调其在临床证据、产品互通性和供应链韧性方面的投资，以确保能够掌握血管内影像技术日益增长的作用。首先，企业必须优先进行可操作的临床研究，以明确血管内超音波何时能显着改善手术效果，以及哪些指标对临床医师和支付者最为重要。此类证据应旨在支持有关指南纳入和报销的讨论。其次，专注于开放标准以及与导管室系统、生理测量平台和电子健康记录的互通性，将降低推广应用的门槛，并支持收集长期数据以证明其价值。

综合调查方法将临床医生和工程师的一手知识与二手文献综述和技术检验相结合，确保了严谨透明的分析。

本分析的研究基础是将与介入性心臟病专家、血管专家、采购经理和器械工程师的初步定性访谈，与临床文献、监管指南和技术评估的严谨的二次研究相结合。初步资料包括旨在识别未满足的临床需求、手术流程和采购决策标准的结构化访谈和咨询会议。除这些访谈外，还对导管设计、感测器架构和主机软体功能进行了技术评估，并将产品的功能集和应用案例进行了匹配。

这篇摘要重点介绍了血管内超音波向不可或缺的图像引导工具的转变，以及将决定未来主导的策略行动。

血管内超音波正处于转折点，技术成熟度、临床需求和商业策略在此交汇融合，推动其在心血管和周边血管介入治疗中发挥越来越重要的作用。该技术能够在手术过程中提供可操作的信息，使其提案超越了单纯的解剖成像，成为精准治疗计划和检验的基础。随着临床指南和临床医生期望的不断演变，能够将产品创新与可操作的证据生成、全面的培训和灵活的商业模式相结合的相关人员，将有机会引领该技术的普及应用。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：血管内超音波市场：依产品类型划分

  • IVUS导管
    • 阵列导管
    • 一体式导管
  • IVUS主机
    • 可携式主机
    • 推车式主机

第九章：血管内超音波市场（依模式划分）

  • 虚拟组织学（VH）血管内超音波
  • iMAP IVUS
  • 整合反向散射（IB）血管内超音波

第十章 血管内超音波市场：依应用领域划分

  • 冠状动脉
    • 急性冠状动脉症候群
    • 慢性完全闭塞
  • 外围
    • 周边动脉疾病
    • 週边静脉输液

第十一章 血管内超音波市场：依最终用途划分

  • 门诊手术中心
  • 医院
  • 研究机构

第十二章 血管内超音波市场：依分销管道划分

  • 直销
  • 透过分销商销售
  • 线上电子采购平台

第十三章 血管内超音波市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 血管内超音波市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 血管内超音波市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国血管内超音波市场

第十七章：中国血管内超音波市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • ACIST Medical Systems by Bracco SpA
  • Avinger, Inc.
  • B. Braun SE
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Conavi Medical Inc.
  • Esaote SpA
  • Fujifilm Corporation
  • GE HealthCare Technologies Inc.
  • GERMITEC
  • Hologic, Inc.
  • Infraredx, Inc. by Nipro Company
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic plc
  • Samsung Electronics Co., Ltd
  • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • Siemens AG
  • SonoScape Medical Corp.
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-F6513A06BEE8

The Intravascular Ultrasound Market was valued at USD 2.67 billion in 2025 and is projected to grow to USD 2.84 billion in 2026, with a CAGR of 6.85%, reaching USD 4.24 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.67 billion
Estimated Year [2026] USD 2.84 billion
Forecast Year [2032] USD 4.24 billion
CAGR (%) 6.85%

Foundational overview of intravascular ultrasound developments and clinical integration shaping procedural decision-making and device selection in contemporary cardiovascular care

Intravascular ultrasound (IVUS) has evolved from an investigational adjunct to a frontline imaging modality that materially influences interventional strategy and device selection. Recent advances in acoustic array technology, higher-resolution imaging modes, and improved catheter designs have narrowed the gap between intravascular imaging and real-time procedural guidance, enabling clinicians to visualize vessel morphology, quantify plaque burden, and optimize device sizing with greater confidence. As a result, IVUS increasingly factors into complex coronary and peripheral interventions, supporting improved procedural precision and potentially better clinical outcomes.

Across care settings, adoption is driven by a combination of clinical evidence, operator training, and equipment accessibility. Technological synergies with complementary modalities, software-enabled analytics for automated measurements, and integration with cath lab workflows are shaping clinician expectations. Simultaneously, regulatory scrutiny and reimbursement pathways continue to influence procurement choices and deployment strategies. Taken together, these factors establish IVUS as both a clinical and commercial focal point for stakeholders seeking to differentiate through imaging-enabled value propositions.

Transformative convergence of higher-resolution imaging, software automation, and clinical evidence generation that is redefining the role of intravascular ultrasound in intervention planning

The IVUS landscape is being reshaped by a convergence of technology innovation, shifting clinical guidelines, and new expectations for procedural outcomes. High-frequency array catheters and improved signal processing algorithms now permit clearer delineation of plaque components and stent apposition, reducing reliance on fluoroscopic inference. Concurrently, enhanced software suites that provide automated lumen and plaque metrics are enabling faster interpretation and consistent reporting across operators, which supports standardized procedural endpoints and comparative outcomes analysis.

Moreover, procedural emphasis has migrated from purely anatomical success to functional and durability metrics, prompting clinicians to integrate IVUS findings with physiological assessments and intraprocedural decision-making. This shift encourages vendors to offer platforms that are interoperable with existing cath lab systems and that support data export for registries and longitudinal follow-up. In parallel, an ecosystem of partnerships between device manufacturers, software developers, and clinical centers is accelerating evidence generation and adoption. Taken together, these transformative shifts are redefining value propositions for IVUS across clinical, operational, and commercial dimensions.

Assessment of how 2025 United States tariff shifts have catalyzed supply chain realignment, sourcing diversification, and alternative commercial models for intravascular ultrasound stakeholders

Tariff adjustments and trade policy changes introduced in the United States in 2025 have exerted a complex influence on procurement, supply chains, and pricing strategies for medical imaging hardware and disposable devices. For IVUS, which relies on precision-engineered catheters, custom transducer materials, and console electronics, increased import duties can elevate landed costs. In response, manufacturers have prioritized regional sourcing diversification, nearshoring of key components, and redesigns that reduce dependency on tariff-affected inputs while preserving clinical performance.

Transitioning supply chains is not instantaneous; lead times for qualification, validation, and regulatory submission impose temporal friction. Consequently, healthcare providers have adopted staged purchasing strategies and longer-term service agreements to mitigate price volatility. At the same time, distributors and OEMs have explored alternative commercial models, including bundled service offerings and subscription-based access to consoles, to smooth revenue recognition and maintain customer relationships. From an innovation perspective, tariffs have incentivized investment in domestic manufacturing capacity and local assembly, which over time may strengthen supply resilience but also require careful capital planning and workforce development. Ultimately, the cumulative impact has been to accelerate strategic supply chain realignment while prompting more creative contracting approaches between providers and vendors.

Compelling segmentation-driven insights that link clinical applications, device typologies, end-use environments, and procedural roles to actionable product and commercialization priorities

Insightful segmentation analysis reveals where clinical demand, product design, and procurement priorities intersect across application, device type, end use, and procedural purpose. When applications are parsed into coronary and peripheral domains, with coronary further distinguished by acute coronary syndrome and chronic total occlusion and peripheral use differentiated into peripheral artery disease and peripheral venous applications, it becomes clear that imaging requirements diverge by lesion complexity, vessel size, and the need for longitudinal vessel assessment. These clinical distinctions drive catheter geometry, frequency selection, and image processing features that product teams prioritize.

Similarly, examining device type illuminates differing value chains and user workflows. Catheters split into array catheters and single element catheters reflect trade-offs between image fidelity, cost per use, and compatibility, while console segmentation into portable and stationary consoles highlights the demand for mobility in ambulatory and hybrid settings versus the capacity and performance expectations in hospital cath labs. End-use environments such as ambulatory surgical centers, hospitals, and research institutes each impose unique procurement cycles, capital approval processes, and integration requirements, which in turn influence decisions on capital expenditure versus disposable purchases. Finally, procedural segmentation into diagnostic and guidance functions-where diagnostic subcategories include lumen measurement and plaque characterization, and guidance subcategories include atherectomy support and stent placement-clarifies clinical workflows and evidence needs. Diagnostic applications emphasize quantitative reproducibility and reporting, while guidance applications demand real-time visualization, robust catheter handling, and integration with therapeutic devices. By synthesizing these axes of segmentation, companies can prioritize product features, clinical validation plans, and commercialization pathways aligned to specific clinical use cases and buyer profiles.

Regional adoption patterns and strategic imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence clinical uptake and commercialization pathways

Regional dynamics are critical to understanding adoption patterns and strategic priorities for IVUS. In the Americas, clinical emphasis on interventional cardiology innovation, well-established reimbursement frameworks for complex procedures, and a concentration of high-volume centers have supported advanced imaging adoption and a competitive service market. Regulatory pathways and procurement practices in the region place a premium on robust clinical outcomes and cost-effectiveness demonstrations, which influences how vendors prioritize clinical evidence and post-market surveillance.

In Europe, Middle East & Africa, the landscape is more heterogeneous, with marked variation in healthcare funding, access to advanced cath lab infrastructure, and local regulatory frameworks. This heterogeneity requires adaptive market entry strategies, partnerships with regional distributors, and flexible pricing approaches. In the Asia-Pacific region, rapid expansion of interventional capabilities, investment in domestic manufacturing, and growing clinical research activity are notable. Many health systems in that region are simultaneously building capacity in tertiary centers and broadening access through ambulatory settings, creating opportunities for both portable consoles and differentiated catheter designs. Across regions, differences in clinical practice patterns and procurement cycles necessitate tailored evidence generation and commercial models that reflect local payer expectations and operational realities.

Competitive and collaborative dynamics showing how hardware leaders, niche innovators, and software entrants are shaping product differentiation and market positioning in intravascular ultrasound

Competitive dynamics in the IVUS space continue to favor organizations that can integrate hardware excellence with software-enabled analytics and strong clinical support. Established medical device firms often leverage scale, deep clinical relationships, and global distribution networks to maintain leadership, while specialized imaging innovators compete on image resolution, catheter design, and workflow integration. Emerging entrants-including small-cap technology firms and software developers-are challenging conventions by focusing on machine learning-driven plaque analysis, automated reporting, and cloud-enabled data management that supports multicenter registries and post-market evidence collection.

Partnerships and strategic collaborations are increasingly important, whether through co-development agreements with therapeutic device manufacturers, licensing of advanced signal-processing algorithms, or consortium-based clinical studies that accelerate guideline inclusion. In addition, aftermarket services, training programs, and procedural decision-support tools have become differentiators that influence purchasing decisions. Successful companies balance investment in R&D with pragmatic commercialization strategies that prioritize interoperability, total cost of ownership considerations, and demonstrable clinical value delivered through improved procedural efficiency and patient outcomes.

Actionable strategic recommendations for manufacturers and providers to align evidence generation, interoperability, supply resilience, and education programs to accelerate intravascular ultrasound adoption

Leaders in the IVUS ecosystem should align investments across clinical evidence, product interoperability, and supply chain resilience to capture the expanding role of intravascular imaging. First, companies must prioritize pragmatic clinical studies that clarify when intravascular ultrasound materially improves procedural outcomes and which metrics matter most to operators and payers; such evidence should be designed to support guideline inclusion and reimbursement discussions. Second, focusing on open standards and interoperability with cath lab systems, physiologic measurement platforms, and electronic health records will lower barriers to adoption and support longitudinal data capture for value demonstration.

Operationally, vendors should diversify component sourcing, invest in regional manufacturing partnerships where feasible, and offer flexible commercial models that include service bundles, pay-per-use, or subscription options for consoles. Training and education remain critical; therefore, scalable programs that combine hands-on simulation, remote proctoring, and data-driven feedback loops will accelerate operator proficiency and adoption. Finally, executives should pursue targeted collaborations with therapeutic device manufacturers and software firms to co-create integrated solutions for guidance during atherectomy and stent placement, thereby strengthening clinical propositions and creating barrier-to-entry effects against less integrated competitors.

Comprehensive research methodology blending primary clinician and engineering insights with secondary literature review and technical validation to ensure rigorous, transparent analysis

The research underpinning this analysis synthesizes primary qualitative engagement with interventional cardiologists, vascular specialists, procurement leaders, and device engineers alongside rigorous secondary review of clinical literature, regulatory guidance, and technology assessments. Primary inputs included structured interviews and advisory discussions designed to uncover unmet clinical needs, procedural workflows, and procurement decision criteria. These conversations were complemented by technical assessments of catheter designs, transducer architectures, and console software capabilities to map product feature sets against clinical use cases.

Secondary research included peer-reviewed clinical studies, guideline statements, and regulatory documentation to validate clinical efficacy and safety considerations without extrapolating market volumes. Data triangulation techniques were applied to reconcile disparate inputs and surface consensus views, while limitations were clearly documented where evidence is emerging or heterogeneous. Throughout the process, methodological rigor was maintained through expert validation rounds, conflict-of-interest screening for interview participants, and adherence to ethical research standards for confidentiality and informed consent. This approach ensures that findings are grounded in contemporary clinical practice and technical feasibility while being transparent about areas that warrant further prospective study.

Concluding synthesis that highlights intravascular ultrasound's transition to an indispensable image-guided tool and the strategic actions that determine future leadership

Intravascular ultrasound stands at an inflection point where technological maturity, clinical expectations, and commercial strategy converge to expand its role in cardiovascular and peripheral interventions. The modality's capacity to provide actionable intraprocedural information has elevated its value proposition beyond anatomical imaging to a cornerstone of precision therapy planning and verification. As clinical guidelines and operator expectations evolve, stakeholders who align product innovation with pragmatic evidence generation, robust training, and flexible commercial models will be positioned to lead adoption curves.

Looking forward, the interplay of regional healthcare dynamics, supply chain adjustments, and software-driven analytics will determine which applications and device configurations gain the most traction. Strategic investments in interoperability and integrated procedural solutions will differentiate winners from followers, while partnerships that accelerate clinical validation and reimbursement pathways will unlock broader clinical utility. In sum, IVUS is transitioning from a specialized adjunct to an indispensable tool for interventionalists seeking reproducible, image-guided outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravascular Ultrasound Market, by Product Type

  • 8.1. IVUS Catheters
    • 8.1.1. Array Catheters
    • 8.1.2. Single Element Catheters
  • 8.2. IVUS Consoles
    • 8.2.1. Portable Consoles
    • 8.2.2. Cart-Based Consoles

9. Intravascular Ultrasound Market, by IVUS Modalities

  • 9.1. Virtual Histology (VH) IVUS
  • 9.2. iMAP IVUS
  • 9.3. Integrated Backscatter (IB) IVUS

10. Intravascular Ultrasound Market, by Application

  • 10.1. Coronary
    • 10.1.1. Acute Coronary Syndrome
    • 10.1.2. Chronic Total Occlusion
  • 10.2. Peripheral
    • 10.2.1. Peripheral Artery Disease
    • 10.2.2. Peripheral Venous Applications

11. Intravascular Ultrasound Market, by End Use

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Research Institutes

12. Intravascular Ultrasound Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributor Sales
  • 12.3. Online & E-Procurement Platforms

13. Intravascular Ultrasound Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Intravascular Ultrasound Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Intravascular Ultrasound Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Intravascular Ultrasound Market

17. China Intravascular Ultrasound Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. ACIST Medical Systems by Bracco S.p.A.
  • 18.7. Avinger, Inc.
  • 18.8. B. Braun SE
  • 18.9. Boston Scientific Corporation
  • 18.10. Canon Medical Systems Corporation
  • 18.11. Conavi Medical Inc.
  • 18.12. Esaote S.p.A
  • 18.13. Fujifilm Corporation
  • 18.14. GE HealthCare Technologies Inc.
  • 18.15. GERMITEC
  • 18.16. Hologic, Inc.
  • 18.17. Infraredx, Inc. by Nipro Company
  • 18.18. Johnson & Johnson
  • 18.19. Koninklijke Philips N.V.
  • 18.20. Medtronic plc
  • 18.21. Samsung Electronics Co., Ltd
  • 18.22. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • 18.23. Siemens AG
  • 18.24. SonoScape Medical Corp.
  • 18.25. Stryker Corporation
  • 18.26. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRAVASCULAR ULTRASOUND MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CART-BASED CONSOLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CART-BASED CONSOLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CART-BASED CONSOLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY VIRTUAL HISTOLOGY (VH) IVUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY VIRTUAL HISTOLOGY (VH) IVUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY VIRTUAL HISTOLOGY (VH) IVUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IMAP IVUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IMAP IVUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IMAP IVUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY INTEGRATED BACKSCATTER (IB) IVUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY INTEGRATED BACKSCATTER (IB) IVUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY INTEGRATED BACKSCATTER (IB) IVUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ONLINE & E-PROCUREMENT PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ONLINE & E-PROCUREMENT PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ONLINE & E-PROCUREMENT PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 169. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 170. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 171. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 174. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 175. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 199. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 200. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 201. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 204. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 205. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 209. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 210. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 211. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 213. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 214. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 215. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)